Skip to main content

Allergen Exposure Planner

Free Allergen exposure Calculator for ai enhanced. Enter parameters to get optimized results with detailed breakdowns. Free to use with no signup required.

Skip to calculator
AI & Predictive Tools

Allergen Exposure Planner

Plan and visualize allergen immunotherapy dose escalation schedules. Calculate build-up timeline, number of steps, and dose progression for OIT protocols.

Last updated: December 2025

Calculator

Adjust values & calculate
0.5 mg
300 mg
25%
14 days
30 kg
Build-Up Timeline
58.0 weeks
30 escalation steps over 13.3 months
Total Steps
30
Total Days
406
Risk Profile
Standard
Start Dose / kg
0.017 mg/kg
Target Dose / kg
10.000 mg/kg

Dose Escalation Schedule

Step 1 (Week 0.0)
0.50 mg(0.017 mg/kg)
Step 2 (Week 2.0)
0.63 mg(0.021 mg/kg)
Step 3 (Week 4.0)
0.78 mg(0.026 mg/kg)
Step 4 (Week 6.0)
0.98 mg(0.033 mg/kg)
Step 5 (Week 8.0)
1.22 mg(0.041 mg/kg)
Step 6 (Week 10.0)
1.53 mg(0.051 mg/kg)
Step 7 (Week 12.0)
1.91 mg(0.064 mg/kg)
Step 8 (Week 14.0)
2.38 mg(0.079 mg/kg)
Step 9 (Week 16.0)
2.98 mg(0.099 mg/kg)
Step 10 (Week 18.0)
3.73 mg(0.124 mg/kg)
Step 11 (Week 20.0)
4.66 mg(0.155 mg/kg)
Step 12 (Week 22.0)
5.82 mg(0.194 mg/kg)
Step 13 (Week 24.0)
7.28 mg(0.243 mg/kg)
Step 14 (Week 26.0)
9.09 mg(0.303 mg/kg)
Step 15 (Week 28.0)
11.37 mg(0.379 mg/kg)
Step 16 (Week 30.0)
14.21 mg(0.474 mg/kg)
Step 17 (Week 32.0)
17.76 mg(0.592 mg/kg)
Step 18 (Week 34.0)
22.20 mg(0.740 mg/kg)
Step 19 (Week 36.0)
27.76 mg(0.925 mg/kg)
Step 20 (Week 38.0)
34.69 mg(1.156 mg/kg)
Step 21 (Week 40.0)
43.37 mg(1.446 mg/kg)
Step 22 (Week 42.0)
54.21 mg(1.807 mg/kg)
Step 23 (Week 44.0)
67.76 mg(2.259 mg/kg)
Step 24 (Week 46.0)
84.70 mg(2.823 mg/kg)
Step 25 (Week 48.0)
105.88 mg(3.529 mg/kg)
Step 26 (Week 50.0)
132.35 mg(4.412 mg/kg)
Step 27 (Week 52.0)
165.44 mg(5.515 mg/kg)
Step 28 (Week 54.0)
206.80 mg(6.893 mg/kg)
Step 29 (Week 56.0)
258.49 mg(8.616 mg/kg)
Step 30 (Week 58.0)
300.00 mg(10.000 mg/kg)
Medical Disclaimer: This planner is for educational visualization only. NEVER self-administer allergen immunotherapy. All OIT must be supervised by a board-certified allergist. Always have injectable epinephrine available. Individual protocols differ significantly based on patient-specific clinical assessments.
Your Result
30 steps over 58.0 weeks (13.3 months) | Risk: Standard
Share Your Result
Understand the Math

Formula

Dose(n) = StartDose x (1 + EscalationRate)^n; Steps = log(TargetDose/StartDose) / log(1 + Rate)

Each step increases the dose by a fixed percentage (escalation rate). The number of steps is determined by how many multiplications are needed to go from the starting dose to the target dose. Total duration equals the number of steps multiplied by the interval between dose increases.

Last reviewed: December 2025

Worked Examples

Example 1: Peanut OIT Standard Protocol

A 30 kg child begins peanut OIT at 0.5 mg protein, targeting 300 mg maintenance dose, with 25% dose escalation every 14 days. How long will the build-up take?
Solution:
Starting dose: 0.5 mg (0.017 mg/kg) Escalation: 25% increase every 2 weeks Steps: 0.5, 0.63, 0.78, 0.98, 1.22, 1.53, ... 300 mg Number of escalation steps: approximately 28 Total duration: 28 x 14 = 392 days (approximately 56 weeks) Cumulative exposure during build-up: ~4,200 mg
Result: 28 steps over approximately 56 weeks (13 months) to reach 300 mg maintenance dose

Example 2: Milk OIT Accelerated Protocol

A 25 kg child starts milk OIT at 1 mg protein with a 40% escalation rate every 7 days, targeting 2000 mg (about 60 ml of milk).
Solution:
Starting dose: 1 mg (0.04 mg/kg) Escalation: 40% increase weekly Steps: 1, 1.4, 1.96, 2.74, ... 2000 mg Number of steps: approximately 23 Total duration: 23 x 7 = 161 days (about 23 weeks) Risk level: Accelerated โ€” higher reaction risk
Result: 23 steps over approximately 23 weeks (5.4 months) to reach 2000 mg โ€” accelerated risk profile
Expert Insights

Background & Theory

The Allergen Exposure Planner applies the following established principles and formulas. Large language models process text by breaking it into tokens, sub-word units produced by algorithms such as byte-pair encoding. In English, one token approximates four characters or three-quarters of a word on average, though this ratio varies considerably across languages and code. A 1000-word document typically requires around 1300 to 1500 tokens. Token count drives both context window constraints and inference billing, making accurate estimation essential for budgeting API usage. The capability of a neural network scales primarily with its parameter count. Parameters are the numerical weights adjusted during training via gradient descent. GPT-3 contains 175 billion parameters; larger models in the trillion-parameter range require correspondingly greater compute and memory. Training compute is measured in floating-point operations (FLOPs): the Chinchilla scaling laws derived by Hoffmann et al. in 2022 show that optimal training allocates roughly 20 tokens per parameter, meaning a 70B-parameter model benefits from approximately 1.4 trillion training tokens. Inference latency depends on model size, hardware, and batching strategy. Running a 7B-parameter model in FP16 precision requires roughly 14 GB of GPU VRAM (2 bytes per parameter), while INT8 quantisation halves this to around 7 GB with modest quality loss, and INT4 reduces it to approximately 3.5 GB. This quantisation trade-off between memory, speed, and accuracy is central to deploying models on consumer hardware. Perplexity measures how surprised a language model is by a given text corpus; lower perplexity indicates better predictive accuracy. Embedding dimensions determine the size of the dense vector representations used to encode semantic meaning. Models like OpenAI's text-embedding-ada-002 produce 1536-dimensional vectors, while compact models may use 384 dimensions. Context window size defines the maximum token span a model can attend to in a single forward pass. Extending context windows from 4K to 128K tokens enables document-scale reasoning but substantially increases memory requirements, as the attention mechanism scales quadratically with sequence length without architectural modifications such as flash attention.

History

The history behind the Allergen Exposure Planner traces back through the following developments. The mathematical neuron model published by Warren McCulloch and Walter Pitts in 1943 first proposed that logical functions could be computed by networks of simple threshold units, planting the seed of neural computation. Frank Rosenblatt's Perceptron, introduced in 1957 and implemented in custom hardware by 1960, could learn linear classifiers from examples and generated enormous public excitement before Marvin Minsky and Seymour Papert's 1969 book rigorously analysed its fundamental limitations, demonstrating it could not learn the simple XOR function. The first AI winter, roughly 1974 to 1980, followed as funding agencies in the US and UK grew disillusioned with unrealised promises. A second wave of interest during the 1980s produced rule-based expert systems deployed in medicine and finance, and saw the re-derivation of backpropagation by Rumelhart, Hinton, and Williams in 1986, making it practical to train multi-layer networks on real problems. A second winter from 1987 to 1993 followed as expert systems proved brittle and hardware remained insufficient for genuine deep learning. The deep learning revival crystallised at the ImageNet Large Scale Visual Recognition Challenge in 2012, when Alex Krizhevsky's convolutional network AlexNet slashed the top-5 error rate by nearly 11 percentage points compared to the prior year's winner. This demonstrated that deep networks trained on GPUs with large labelled datasets could achieve human-competitive image recognition. Subsequent years saw rapid advances in recurrent networks, sequence-to-sequence models, and the attention mechanism, culminating in the transformer architecture introduced by Vaswani et al. in 2017. OpenAI released GPT-1 in 2018, demonstrating that unsupervised pre-training on large text corpora followed by task-specific fine-tuning could transfer knowledge broadly across language tasks. GPT-2 in 2019 demonstrated surprisingly fluent long-form text generation. GPT-3 in 2020, with 175 billion parameters, showed that scale alone could unlock few-shot learning. Kaplan et al.'s 2020 scaling laws paper provided the theoretical grounding. ChatGPT launched in November 2022, reaching one million users within five days and igniting mainstream global awareness of large language models.

Share this calculator

Explore More

Frequently Asked Questions

Oral immunotherapy is a medical treatment approach for food allergies in which patients consume gradually increasing doses of the allergen under medical supervision to build tolerance over time. The process typically involves three phases: an initial dose escalation day performed in a clinical setting, a build-up phase lasting several months where doses are gradually increased at regular intervals, and a maintenance phase where the patient continues consuming the target dose daily. An allergen exposure planner helps map out the escalation schedule by calculating the number of steps, timeline, and dose progression from a very small starting dose to the target maintenance dose. This planning tool is meant for educational visualization only and all actual treatment must be supervised by a board-certified allergist experienced in food allergy immunotherapy protocols.
Oral immunotherapy carries real risks including mild, moderate, and potentially severe allergic reactions during the treatment process. Common side effects include oral itching or tingling, mild abdominal discomfort, and occasional nausea, occurring in approximately 10 to 20 percent of doses. More concerning reactions such as hives, vomiting, or throat tightness occur less frequently but require medical attention. Anaphylaxis, though rare, is a life-threatening risk that can occur at any point during treatment, which is why patients must always have injectable epinephrine available. Risk factors that increase reaction likelihood include exercise within two hours of dosing, illness or infection, menstruation, high pollen season for cross-reactive allergens, and taking the dose on an empty stomach. All OIT patients require regular follow-up with their treating allergist throughout the entire treatment process.
Absolutely not. This allergen exposure planner is designed exclusively for educational and visualization purposes to help patients and families understand the general structure and timeline of allergen immunotherapy protocols. It should never be used to design, modify, or self-administer an allergen immunotherapy protocol without direct supervision from a board-certified allergist or immunologist. Food allergy immunotherapy involves significant medical risks including anaphylaxis, and every patient requires individualized assessment, dose determination, and ongoing monitoring by qualified medical professionals. The dosing schedules shown here are simplified mathematical models that do not account for individual patient factors such as baseline sensitivity, comorbidities, concurrent medications, or real-time allergic reactions that may require dose adjustments. Always consult your allergist before making any changes to your treatment plan.
You may use the results for reference and educational purposes. For professional reports, academic papers, or critical decisions, we recommend verifying outputs against peer-reviewed sources or consulting a qualified expert in the relevant field.
All calculations use established mathematical formulas and are performed with high-precision arithmetic. Results are accurate to the precision shown. For critical decisions in finance, medicine, or engineering, always verify results with a qualified professional.
No. All calculations run entirely in your browser using JavaScript. No data you enter is ever transmitted to any server or stored anywhere. Your inputs remain completely private.
Educational Note: This calculator is provided for educational and informational purposes. Results are based on the formulas and inputs provided. Always verify important calculations independently. NovaCalculator processes calculator inputs client-side; optional analytics follow visitor consent settings. ยฉ 2024โ€“2026 NovaCalculator.

Share this calculator

Formula

Dose(n) = StartDose x (1 + EscalationRate)^n; Steps = log(TargetDose/StartDose) / log(1 + Rate)

Each step increases the dose by a fixed percentage (escalation rate). The number of steps is determined by how many multiplications are needed to go from the starting dose to the target dose. Total duration equals the number of steps multiplied by the interval between dose increases.

Worked Examples

Example 1: Peanut OIT Standard Protocol

Problem: A 30 kg child begins peanut OIT at 0.5 mg protein, targeting 300 mg maintenance dose, with 25% dose escalation every 14 days. How long will the build-up take?

Solution: Starting dose: 0.5 mg (0.017 mg/kg)\nEscalation: 25% increase every 2 weeks\nSteps: 0.5, 0.63, 0.78, 0.98, 1.22, 1.53, ... 300 mg\nNumber of escalation steps: approximately 28\nTotal duration: 28 x 14 = 392 days (approximately 56 weeks)\nCumulative exposure during build-up: ~4,200 mg

Result: 28 steps over approximately 56 weeks (13 months) to reach 300 mg maintenance dose

Example 2: Milk OIT Accelerated Protocol

Problem: A 25 kg child starts milk OIT at 1 mg protein with a 40% escalation rate every 7 days, targeting 2000 mg (about 60 ml of milk).

Solution: Starting dose: 1 mg (0.04 mg/kg)\nEscalation: 40% increase weekly\nSteps: 1, 1.4, 1.96, 2.74, ... 2000 mg\nNumber of steps: approximately 23\nTotal duration: 23 x 7 = 161 days (about 23 weeks)\nRisk level: Accelerated โ€” higher reaction risk

Result: 23 steps over approximately 23 weeks (5.4 months) to reach 2000 mg โ€” accelerated risk profile

Frequently Asked Questions

What is oral immunotherapy (OIT) and how does allergen exposure planning work?

Oral immunotherapy is a medical treatment approach for food allergies in which patients consume gradually increasing doses of the allergen under medical supervision to build tolerance over time. The process typically involves three phases: an initial dose escalation day performed in a clinical setting, a build-up phase lasting several months where doses are gradually increased at regular intervals, and a maintenance phase where the patient continues consuming the target dose daily. An allergen exposure planner helps map out the escalation schedule by calculating the number of steps, timeline, and dose progression from a very small starting dose to the target maintenance dose. This planning tool is meant for educational visualization only and all actual treatment must be supervised by a board-certified allergist experienced in food allergy immunotherapy protocols.

What are the risks and side effects associated with allergen exposure therapy?

Oral immunotherapy carries real risks including mild, moderate, and potentially severe allergic reactions during the treatment process. Common side effects include oral itching or tingling, mild abdominal discomfort, and occasional nausea, occurring in approximately 10 to 20 percent of doses. More concerning reactions such as hives, vomiting, or throat tightness occur less frequently but require medical attention. Anaphylaxis, though rare, is a life-threatening risk that can occur at any point during treatment, which is why patients must always have injectable epinephrine available. Risk factors that increase reaction likelihood include exercise within two hours of dosing, illness or infection, menstruation, high pollen season for cross-reactive allergens, and taking the dose on an empty stomach. All OIT patients require regular follow-up with their treating allergist throughout the entire treatment process.

Is Allergen Exposure Planner a substitute for medical advice on allergen immunotherapy?

Absolutely not. This allergen exposure planner is designed exclusively for educational and visualization purposes to help patients and families understand the general structure and timeline of allergen immunotherapy protocols. It should never be used to design, modify, or self-administer an allergen immunotherapy protocol without direct supervision from a board-certified allergist or immunologist. Food allergy immunotherapy involves significant medical risks including anaphylaxis, and every patient requires individualized assessment, dose determination, and ongoing monitoring by qualified medical professionals. The dosing schedules shown here are simplified mathematical models that do not account for individual patient factors such as baseline sensitivity, comorbidities, concurrent medications, or real-time allergic reactions that may require dose adjustments. Always consult your allergist before making any changes to your treatment plan.

How accurate are the results from Allergen Exposure Planner?

All calculations use established mathematical formulas and are performed with high-precision arithmetic. Results are accurate to the precision shown. For critical decisions in finance, medicine, or engineering, always verify results with a qualified professional.

How do I interpret the result?

Results are displayed with a label and unit to help you understand the output. Many calculators include a short explanation or classification below the result (for example, a BMI category or risk level). Refer to the worked examples section on this page for real-world context.

What inputs do I need to use Allergen Exposure Planner accurately?

Each field is labelled with the required unit (metric or imperial). Gather your source values before starting โ€” for example, a weight measurement in kilograms, a distance in metres, or a dollar amount โ€” and enter them exactly as measured. The formula section on this page lists every variable and explains what each represents.

References

Reviewed by Daniel Agrici, Founder & Lead Developer ยท Editorial policy